Walleye Capital
JAZZ icon

Walleye Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History

Walleye Capital’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$189K Sell
1,000
-200
-17% -$35K ﹤0.01% 3378
2025
Q4 		$204K Buy
1,200
+700
+140% +$107K ﹤0.01% 3537
2025
Q3 		$65.9K Buy
+500
New +$60K ﹤0.01% 3899
2024
Q3 		– Sell
-6,100
Closed -$651K – 5579
2024
Q2 		$651K Buy
6,100
+3,300
+118% +$363K ﹤0.01% 3268
2024
Q1 		$337K Buy
2,800
+1,000
+56% +$122K ﹤0.01% 3549
2023
Q4 		$221K Sell
1,800
-5,800
-76% -$724K ﹤0.01% 3616
2023
Q3 		$984K Buy
7,600
+5,200
+217% +$693K ﹤0.01% 2264
2023
Q2 		$298K Buy
2,400
+1,700
+243% +$229K ﹤0.01% 2813
2023
Q1 		$102K Sell
700
-2,000
-74% -$296K ﹤0.01% 2920
2022
Q4 		$430K Sell
2,700
-4,400
-62% -$645K 0.01% 1550
2022
Q3 		$946K Buy
+7,100
New +$1.08M 0.02% 1022
2020
Q1 		– Sell
-10,600
Closed -$1.58M – 1299
2019
Q4 		$1.58M Sell
10,600
-73,400
-87% -$9.99M 0.1% 272
2019
Q3 		$10.8M Buy
84,000
+62,900
+298% +$8.43M 0.64% 11
2019
Q2 		$3.01M Buy
21,100
+13,200
+167% +$1.77M 0.33% 36
2019
Q1 		$1.13M Buy
+7,900
New +$1.03M 0.19% 131

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Walleye Capital's JAZZ Position: Q1 2026 in Review

Walleye Capital reduced its Jazz Pharmaceuticals (JAZZ) stake by 25% in Q1 2026, selling an estimated $4.96M and leaving 87,365 shares worth $16.5M. The position accounts for 0.07% of the portfolio, ranked #244.

Walleye Capital first reported a position in JAZZ in Q1 2019 and has held it in 15 quarters since. The position peaked at $19.7M in Q4 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Walleye Capital held 87,365 shares of Jazz Pharmaceuticals worth $16.5M as of Q1 2026.
  • Walleye Capital sold 28,393 Jazz Pharmaceuticals shares in Q1 2026, an estimated $4.96M.
  • Jazz Pharmaceuticals made up 0.07% of Walleye Capital's portfolio in Q1 2026, its #244 holding.
  • Walleye Capital first reported a position in Jazz Pharmaceuticals in Q1 2019 and has held it in 15 quarters since.
  • Walleye Capital's Jazz Pharmaceuticals position peaked at $19.7M in Q4 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.